Leukemia Research Reports is an Open Access journal
This journal is a peer reviewed, Open Access journal.
All articles published Open Access will be immediately and permanently free for everyone to read, download, copy and distribute. Permitted reuse is defined by your choice of one of the following user licenses:
Creative Commons Attribution-Non Commercial-ShareAlike (CC BY-NC-SA): for non-commercial purposes, lets others distribute and copy the article, to create extracts, abstracts and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text and data mine the article, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, do not modify the article in such a way as to damage the author's honor or reputation, and license their new adaptations or creations under identical terms (CC BY NC SA).
Creative Commons Attribution-NonCommercial-NoDerivs (CC-BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.
If you need to comply with your funding body policy you can apply for a CC-BY license after your manuscript is accepted for publication.
Open Access Publication Fee
As an Open Access journal with no subscription charges, a fee is payable by the author or research funder to cover the costs associated with publication. This ensures your article will be immediately and permanently free to access by everyone.
The Open Access publication fee for this journal is $USD 600, excluding taxes.
If you would like your article to be published open access, but you genuinely cannot afford these fees, then individual waiver requests are considered on a case-by-case basis and may be granted in cases of genuine need. Priority for this waiver program will be given to applications by authors from countries eligible for the Research4Life program.
Funding Body Agreements
Elsevier has established agreements with funding bodies, including Wellcome Trust and Research Councils UK. This ensures authors can comply with funding body Open Access policies and may also be reimbursed for their publication fees.
For Open Access publishing this journal uses an exclusive licensing agreement. Authors will retain copyright alongside scholarly usage rights and Elsevier will be granted publishing and distribution rights.
Learn More about:
• Publishing Open Access with Elsevier
• Funding body agreements
• Open Access license policy